Colony collapse disorder has been the scourge of U.S. beekeepers for more than a decade, contributing to a 30-40 percent plunge in commercial honey bee colonies since 2006.
BOISE – A growing public health crisis is happening all over the world, including our rivers, soil, and hospitals here in Idaho.
“We’ve used tons and tons of antibiotics lately, these bacteria that are resistant are rising in frequency everywhere on the planet basically,” said University of Idaho Professor Eva top, “we’re traveling much more, so if something pops up in China or India, the next day or week it can be in the U.S. or Europe or wherever.”
Grandori’s company SEngine, is preparing for a future in which cancer is not going to be treated according to cancer type – like breast or colon – but it will be treated based on its genetic underpinning.
Nu-Med Plus, a medtech firm based in Utah, has developed a range of smart delivery devices for inhaled nitric oxide delivery, including a miniaturized unit that can operate in a doctor’s office. The innovation has been possible as parts of the drug patent for nitric oxide have been invalidated, meaning that the cost of the treatment could come down.
Read more: http://tiny.cc/5aa62y
There’s a lot of perfectly good space junk floating around up there, such as the upper stages of spent rockets. NanoRacks, a company dedicated to democratizing low-earth orbit by supporting innovations like cheap, easily deployed CubeSats, wants to use those in-space structures to build habitats known as Outposts. The Outposts could prove to be crucial infrastructure for commercial space travel and exploration.
Naturally, the heavy lifting — er, weightless shifting — will fall to robots.
Sounds a little far-fetched, to be sure, but NASA is getting behind the idea. The space agency recently chose NanoRacks as one of 13 companies involved in a study of commercial human spaceflight in Low Earth Orbit (LEO). This week, NanoRacks shared some details about its Space Outpost Program and identified strategic study partners supporting its efforts, including Olis Robotics, which makes remote robotics software.
Angel investing is a tricky game. Supporting a startup just getting off the ground takes a lot of work. But after several years spent as a venture capitalist in the Bay Area, Susan Preston, now the managing member at Seattle’s SeaChange Fund, returned to the Pacific Northwest with an idea for how to spot sound bets for seed investments and then nurture their growth.
And a collaborative due diligence process aimed at both fostering consensus among angel investors and encouraging entrepreneurs is at its heart.
Read more about SeaChange’s transformation here: https://pitchbook.com/news/articles/seattle-angel-fund-rebrands-with-launch-of-seachange-its-largest-raise-to-date
Every patient’s cancer is unique and every patient responds to cancer drugs differently. But right now, all patients with the same kind of cancer are treated with the same drugs.
SEngine Precision Medicine is hoping to change that with new platform, called PARIS, that grows and analyzes a patient’s cancer cells to figure out which drugs will work best for them.
Read the rest right here: https://www.geekwire.com/2018/startup-researchers-get-3-1m-grant-bring-personalized-cancer-fighting-tech-patients/
We’re proud to have cultivated the speaking engagement for Phase Genomics. CEO Ivan Liachko will present on the convergence of technology and the life sciences on June 12th in Seattle, alongside other biotech innovators such as Adaptive Biotechnologies and Silverback Therapeutics.
Find the details and join us here: https://www.xconomy.com/whats-hot-in-seattle-biotech/speakers/